Eric Umbreit (@umbreite) 's Twitter Profile
Eric Umbreit

@umbreite

Associate Prof and Fellowship Director at UT Health San Antonio | Urologic Oncology | Dreaming of Powder

ID: 162252839

calendar_today03-07-2010 03:39:08

280 Tweet

211 Followers

279 Following

Matt Campbell MD, MS (@docmattcampbell) 's Twitter Profile Photo

Great Wood fellow case presentations started by Daniel Shapiro at UT Christopher G Wood Austin conference with Joseph Vento, MD, MS Vikram M. Narayan, MD Dr Justin Matalay Dr Amy Lim Andrew McIntosh Dr Christine Ibilibor Andy Hahn @patrickpilie. Chris’s memory and spirit was well represented

Great Wood fellow case presentations started by <a href="/d_shapiro1/">Daniel Shapiro</a> at UT Christopher G Wood Austin conference with <a href="/JVentoMD/">Joseph Vento, MD, MS</a> <a href="/VikramNarayan/">Vikram M. Narayan, MD</a> Dr Justin Matalay Dr Amy Lim <a href="/McAGES/">Andrew McIntosh</a> Dr Christine Ibilibor <a href="/OncHahn/">Andy Hahn</a> @patrickpilie.  Chris’s memory and spirit was well represented
Gretchen Vaughan (@gevaughan1) 's Twitter Profile Photo

Happy Birthday, Tian! You are brilliant and kind—a wonderful mother, teacher, and friend. The KCA and I are better because you were born! Here’s to making memories today! Tian Zhang, MD, MHS

Happy Birthday, Tian! You are brilliant and kind—a wonderful mother, teacher, and friend. The KCA and I are better because you were born! Here’s to making memories today! <a href="/TiansterZhang/">Tian Zhang, MD, MHS</a>
Toni Choueiri, MD (@drchoueiri) 's Twitter Profile Photo

JUST IN/Big news for #bladdercancer: PDL1 inhibitor Durvalumab regimen demonstrated improvement in DFS for high-risk non-muscle-invasive bladder cancer in POTOMAC Phase III trial. News from AstraZeneca this morning! Bladder Cancer Advocacy Network Dana-Farber Lank Center for Genitourinary Oncology astrazeneca.com/media-centre/p…

JUST IN/Big news for #bladdercancer: PDL1 inhibitor Durvalumab regimen demonstrated improvement in DFS for high-risk non-muscle-invasive bladder cancer in POTOMAC Phase III trial. News from <a href="/AstraZeneca/">AstraZeneca</a> this morning! <a href="/BladderCancerUS/">Bladder Cancer Advocacy Network</a> <a href="/DanaFarber_GU/">Dana-Farber Lank Center for Genitourinary Oncology</a> 

astrazeneca.com/media-centre/p…
Daniel E Spratt (@drspratticus) 's Twitter Profile Photo

X-torial: Cleaning up the misinformation about Joe Biden and #ProstateCancer that I am reading everywhere. The purpose of this is to provide education from someone who treats and studies PCa for a living, lead the USA National Comprehensive Cancer Network (NCCN) PCa guidelines, hold leadership in NRG Oncology National Cancer Institute

Jake Scott, MD (@jakescottmd) 's Twitter Profile Photo

RFK Jr. went on national TV and spouted egregious, dangerous falsehoods about vaccines. As a parent and infectious diseases doctor, I couldn't stay silent. Fox News might not fact-check him, but I will. I've reviewed the trials. I've catalogued them. I have receipts. 🧵

Long School of Medicine (@thelongsom) 's Twitter Profile Photo

UT Health San Antonio (@uthealthsa) is the first in Texas to use a new non-opioid painkiller as a first-line treatment after surgery. A major step toward safer pain care and fighting the opioid crisis. More from Texas Public Radio at bit.ly/4ecTe4O

Bernie Bochner, MD (@bbmdmsk) 's Twitter Profile Photo

A very sad day learning that a giant in urology passed, Donald G. Skinner MD His impact was profound. His commitment to surgical excellence was only matched by his devotion to pt care and teaching. Simply the best mentor, colleague and friend RIP Boss Society of Urologic Oncology Amer. Urol. Assn.

A very sad day learning that a giant in urology passed, Donald G. Skinner MD  His impact was profound. His commitment to surgical excellence was only matched by his devotion to pt care and teaching.  Simply the best mentor, colleague and friend 
RIP Boss 
<a href="/UroOnc/">Society of Urologic Oncology</a> <a href="/AmerUrological/">Amer. Urol. Assn.</a>
Sia Daneshmand, M.D. (@siadaneshmand) 's Twitter Profile Photo

A sad day indeed. He leaves behind a lasting legacy that will endure for decades. His impact on urologic oncology is profound—ranging from teaching meticulous surgical technique to advancing science through basic and clinical research. We are all feeling this loss and are deeply

Dr. Nina Niu Sanford (@niusanford) 's Twitter Profile Photo

💔 💔 💔 Many of us in Texas with young daughters are at most 1 degree of separation from these girls & their families. Just heartbreaking. 🙏 any girls still missing are found alive.

Brogan Dempsey (@brogandempsey4) 's Twitter Profile Photo

Deeply saddened by the destruction that the floods caused. I am praying for all the families and people affected. Some teammates and I drove up to Hunt Texas to help support the community and I encourage everyone to come help out. #TexasStrong We Are Champion Football Charger Athletics

Deeply saddened by the destruction that the floods caused. I am praying for all the families and people affected. Some teammates and I drove up to Hunt Texas to help support the community and I encourage everyone to come help out. #TexasStrong 
<a href="/ChampionHSFB/">We Are Champion Football</a> <a href="/WACAthletics08/">Charger Athletics</a>
Félix Guerrero-Ramos (@drfelixguerrero) 's Twitter Profile Photo

Johnson & Johnson receives U.S. FDA Priority Review for TAR-200 NDA in high-risk non-muscle invasive bladder cancer jnj.com/media-center/p…

UroToday.com (@urotoday) 's Twitter Profile Photo

#COTRIMS study: Reducing long-term toxicity in metastatic seminoma treatment. Axel Heidenreich, MD, PhD Universität zu Köln joins Leslie Ballas Cedars-Sinai to discuss the single-arm COTRIMS study examining nerve-sparing retroperitoneal lymphadenectomy for low-volume metastatic seminoma.

#COTRIMS study: Reducing long-term toxicity in metastatic seminoma treatment. Axel Heidenreich, MD, PhD <a href="/UniCologne/">Universität zu Köln</a> joins <a href="/l_ballas/">Leslie Ballas</a> <a href="/CedarsSinai/">Cedars-Sinai</a> to discuss the single-arm COTRIMS study examining nerve-sparing retroperitoneal lymphadenectomy for low-volume metastatic seminoma.